Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Sanford USD Medical Center - Sioux Falls
mi
from
Sioux Falls, SD
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Sanford USD Medical Center - Sioux Falls
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Franklin, TN
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Wellmont Holston Valley Hospital and Medical Center
mi
from
Kingsport, TN
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Wellmont Holston Valley Hospital and Medical Center
mi
from
Kingsport, TN
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Thompson Cancer Survival Center
mi
from
Knoxville, TN
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Thompson Cancer Survival Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of Tennessee - Knoxville
mi
from
Knoxville, TN
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Tennessee - Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Health Science Center
mi
from
Memphis, TN
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
The Don & Sybil Harrington Cancer Center
mi
from
Amarillo, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
The Don & Sybil Harrington Cancer Center
mi
from
Amarillo, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Austin Midtown
mi
from
Austin, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Austin Midtown
mi
from
Austin, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology-Central Austin Cancer Center
mi
from
Austin, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology-Central Austin Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology, PA at South Austin Cancer Center
mi
from
Austin, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology, PA at South Austin Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology, PA - Austin North
mi
from
Austin, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology, PA - Austin North
mi
from
Austin, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology Seton Northwest
mi
from
Austin, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology Seton Northwest
mi
from
Austin, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Health Presbyterian Hospital Dallas
mi
from
Dallas, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Health Presbyterian Hospital Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Parkland Memorial Hospital
mi
from
Dallas, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Parkland Memorial Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Zale Lipshy University Hospital
mi
from
Dallas, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Zale Lipshy University Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Clements University Hospital
mi
from
Dallas, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Clements University Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Dallas Oncology Consultants PA
mi
from
Duncanville, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Dallas Oncology Consultants PA
mi
from
Duncanville, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
The Center for Integrative Cancer Medicine
mi
from
El Paso, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
The Center for Integrative Cancer Medicine
mi
from
El Paso, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Baylor Saint Luke's Medical Center
mi
from
Houston, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Baylor Saint Luke's Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Ben Taub General Hospital
mi
from
Houston, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Ben Taub General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital System
mi
from
Houston, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital System
mi
from
Houston, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology Seton Williamson
mi
from
Round Rock, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology Seton Williamson
mi
from
Round Rock, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Round Rock Cancer Center
mi
from
Round Rock, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Round Rock Cancer Center
mi
from
Round Rock, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Audie L Murphy Veterans Affairs Hospital
mi
from
San Antonio, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Audie L Murphy Veterans Affairs Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
mi
from
San Antonio, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
University Hospital
mi
from
San Antonio, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - San Marcos
mi
from
San Marcos, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - San Marcos
mi
from
San Marcos, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Scott & White Memorial Hospital
mi
from
Temple, TX
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
American Fork Hospital
mi
from
American Fork, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
American Fork Hospital
mi
from
American Fork, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Sandra L. Maxwell Cancer Center
mi
from
Cedar City, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Sandra L. Maxwell Cancer Center
mi
from
Cedar City, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Logan Regional Hospital
mi
from
Logan, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Logan Regional Hospital
mi
from
Logan, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Cottonwood Hospital Medical Center
mi
from
Murray, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Cottonwood Hospital Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
McKay-Dee Hospital Center
mi
from
Ogden, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
McKay-Dee Hospital Center
mi
from
Ogden, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Utah Valley Regional Medical Center
mi
from
Provo, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Utah Valley Regional Medical Center
mi
from
Provo, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Dixie Medical Center Regional Cancer Center
mi
from
Saint George, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Dixie Medical Center Regional Cancer Center
mi
from
Saint George, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Intermountain Health Care
mi
from
Salt Lake City, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Intermountain Health Care
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Utah Cancer Specialists-Salt Lake City
mi
from
Salt Lake City, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Utah Cancer Specialists-Salt Lake City
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
LDS Hospital
mi
from
Salt Lake City, UT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Southwestern Vermont Medical Center
mi
from
Bennington, VT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Southwestern Vermont Medical Center
mi
from
Bennington, VT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
Central Vermont Medical Center/National Life Cancer Treatment
mi
from
Berlin, VT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
Central Vermont Medical Center/National Life Cancer Treatment
mi
from
Berlin, VT
Click here to add this to my saved trials
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Vermont College of Medicine
mi
from
Burlington, VT
Click here to add this to my saved trials